Alembic Pharmaceuticals Limited has entered into a strategic partnership with Enthral.ai to roll out an advanced AI-powered skilling platform, marking a major step in modernizing its training ecosystem.
ZEISS India has launched its new ClearMind lenses today, bringing a fresh approach to everyday vision. The ClearMind lenses are designed to deliver sharper clarity while reducing the cognitive load caused by blurry vision, making them ideal for...
Biogen said it will acquire Apellis Pharmaceuticals for USD 5.6 billion, marking a major step in its rare disease strategy. The Biogen to buy Apellis deal comes as the company looks to reduce reliance on its aging multiple sclerosis portfolio and...
Nayab Singh Saini has ordered the rollout of a real-time medicine tracking system in Haryana hospitals, aiming to curb outside prescriptions and improve patient care.
Marksans Pharma gets USFDA nod for benzonatate capsules, marking a key step in its push into the US generics market.
Takeda Pharmaceutical Company is a step closer to dengue vaccine Import approval in India after receiving a positive recommendation from the Subject Expert Committee, marking a major development in the country’s fight against mosquito-borne diseases.
VLCC has taken a major step by introducing Global Laser Certification access in India through a new partnership with the National Council on Laser Certification (NCLC), USA. With this move, VLCC becomes the exclusive proctor for NCLC exams...
Indian pharmaceutical firms looking to benefit from the global biologics boom are facing major obstacles, as China's hold on biotech supply chains becomes even stronger.
Sanofi has secured a conditional marketing authorization for Rezurock (belumosudil) in the EU, marking a major step forward in chronic GVHD treatment.
Rusan Healthcare has announced the launch of the APOSAN 3ml Pen, a multi-dose delivery pen device designed for better treatment in Parkinson’s disease ON-OFF episodes.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")